Postdoctoral Research Opportunities Studying factors related to risk of developing cancer – Dr. Thomas Rohan Investigations of novel oncogenic pathways, drug resistance mechanisms, immune biomarkers and new treatment strategies in lung cancer - Drs. Haiying Cheng and Balazs Halmos Studies of the cancer immune micro-environment in specimens from patients using digital spatial profiling and quantitative immunofluorescence to define biomarkers for response to therapy and correlating with data from organoid models.- Dr. Yvonne Saenger Basic and Translational Research to Develop New Therapeutic Strategies in GI Cancers - Dr. Chaoyuan Kuang The Response of Immune and Tumor Microenvironments to Cytotoxic Chemotherapy, using Animal Models of Cancer Progression and Digital Pathology- Dr. Georgios Karagiannis Lung carcinogenesis and inflammation related to epigenetics and clinical factors, using unique DNA methylation and microRNA technologies and airway biomarker strategies, and a large human lung tissue and surrogate repository - Dr. Simon Spivack Using state-of-the-art intravital microscopy in live animals with tumors to study cellular phenotypes promoting cancer metastasis at all sites and stages of cancer progression – Drs. Maja Oktay, John Condeelis, David Entenberg Evaluating mechanism-based therapeutic strategies in adult T-cell leukemia/lymphoma (ATLL) using patient derived preclinical models – Dr. B. Hilda YE Viral determinants of HIV-1 neuropathogenesis, Modulation of ESCRT complexes in HIV-1 budding/release and targeting the RdRP complex of SARS CoV-2 - Dr. Vinayaka R. Prasad Postdoctoral Fellowship in Psycho-Oncology in Bronx, NY - Alyson Moadel-Robblee Biochemical, structural, and biology approaches to understand how Protein Arginine Methyltransferases (PRMTs) regulate genome function - David Shechter Genetic, molecular, and pharmacologic approaches to identify actionable targets and drugs downstream of RB1 in lung and prostate cancer – Dr. Ed Schwartz The impact of genetic and nutrient factors on intestinal stem cells in establishing higher risk for intestinal tumor development in the mouse and humans - Dr. Leonard Augenlicht Studies on the regulation of PI 3-kinases and their role in tumorigenesis and metastasis - Dr. Jonathan Backer Drosophila growth control, cell competition, and neural development - Dr. Nicholas Baker Biology of Hematopoetic stem cells and malignancies - Dr. Meelad Dawlaty Structure, Functional, and Regulation analyses of folate and anitfolate transporters - Dr. I. D. Goldman Lineage plasticity in breast cancer using epigenomics methods, CRSPR genome editing, organoid culture and in-vivo mouse models - Dr. Wenjun Guo Functional differentiation of naive and memory CD8 T cells in vaccines and tumors - Dr. Gregoire Lauvau Host-microbiome interactions - Dr. Sridhar Mani Mechanisms of chemotherapy-mediated senescence - Dr. Hayley McDaid Genomic and Molecular biomarkers for prognosis and targeted treatment in head and neck squamous cell carcinoma - Dr. Thomas Ow Role of dynamic DNA structures in etiology of cancer, fragile X syndrome,autism & telomere dysfunction - Dr. Carl Schildkraut 'Omics level surveys of somatic mutation, methylome, and transcriptomes of lung tissue and tumors with translation to non-invasive exhaled and exfoliated biomarkers of risk for lung cancer - Dr. Simon Spivack The role of labile intracellular iron pools in hematopoietic stem cell maintenance - Dr. Britta Will Characterization of highly selective autophagy pathways in leukemia evolution and maintenance - Dr. Britta Will Function and immunotherapeutic potential of newly discovered T-Cell immune checkpoints - Dr. XingXing Zang To learn more about these projects and their faculty members, please click on the links above. To apply for a position, click on the faculty member name and email your letter of interest, CV, and the names of three references via their Faculty Profile directly or send to: Lauren E Hackett, Deputy Director of Administration, Albert Einstein Cancer Center, at email@example.com. The Albert Einstein College of Medicine is an equal opportunity employer.